Company intelligence / Profile preview

Brooks Medtech

Ownership: Private
Development stage: Commercial

Overview

Brooks Medtech is an active consulting firm specializing in full product lifecycle support for medical technology companies. Their expertise spans ideation, evidence development, clinical trials, regulatory approval (including FDA), and go-to-market strategy. They work with medical device companies, mobile health firms, in vitro diagnostics developers, combination product companies, and cardiovascular drug developers.

Modalities: DeviceCombination product (consulting focus includes combination products)
Industry: Consulting

Drug pipeline

3 assets

DuraGraft

Commercial

Indications: Coronary artery bypass graft surgery

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Brooks Medtech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brooks Medtech.

Explore the full profile